🇺🇸 FDA
Patent

US 10934547

Use of trinucleotide repeat RNAs to treat cancer

granted A61KA61K31/713A61K47/64

Quick answer

US patent 10934547 (Use of trinucleotide repeat RNAs to treat cancer) held by Northwestern University expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/713, A61K47/64, A61K47/6931, A61P